Vascular and Non-HLA autoantibody profiles in hospitalized patients with COVID-19.

导出 LinkOut

翻译打印收藏纠错

第一作者： Brian,Lichtenstein

第一单位： Division of Hospital Medicine, Department of Internal Medicine, Sharp Rees-Stealy Medical Group, Sharp Healthcare, San Diego, CA, United States.

作者： Brian,Lichtenstein ^[1] ; Ying,Zheng ^[2] ; David,Gjertson ^[3] ; Kathie G,Ferbas ^[4] ; Anne W,Rimoin ^[5] ; Otto O,Yang ^[6] ; Grace M,Aldrovandi ^[4] ; Joanna M,Schaenman ^[6] ; Elaine F,Reed ^[2] ; Jennifer A,Fulcher ^[7]

作者单位： Division of Hospital Medicine, Department of Internal Medicine, Sharp Rees-Stealy Medical Group, Sharp Healthcare, San Diego, CA, United States. ^[1] Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States. ^[2] Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.;Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, United States. ^[3] Division of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States. ^[4] Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, United States. ^[5] Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States. ^[6] Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.;Infectious Diseases Section, Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles, CA, United States. ^[7]

关键词 Anti-endothelial antibodies COVID-19 Non-HLA antigens angiotensin II receptor type 1 (AT1R)autoantibody

主题词人类(Humans);自身抗体(Autoantibodies);内皮细胞(Endothelial Cells);自身免疫(Autoimmunity);危险因素(Risk Factors)

DOI 10.3389/fimmu.2023.1197326

PMID 37398658

发布时间 2024-09-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交